A New Era in Schizophrenia Care: FDA Approves Weltruza, the First PDSS-Free Once-Monthly Injectable Olanzapine
By Ian Ingram, Managing Editor, MedPage Today October 9, 2026 In a significant advancement for the management of schizophrenia, the U.S. Food and Drug Administration (FDA) has officially approved Weltruza,…
Unlocking the Monthly Engine: Understanding the Psychology of the Modern Recurring Donor
By Abby Jarvis, Head of Research at Neon One In the rapidly evolving landscape of nonprofit fundraising, the "holy grail" for many organizations is the stability provided by recurring giving…











